A prothrombotic state is associated with early arterial damage in hypertensive patients

Journal of Atherosclerosis and Thrombosis

Volumn 19, Issue 5, 2012, Pages 471-478

  Catena, Cristiana ^a   Colussi, GianLuca ^a   Brosolo, Gabriele ^a   Sechi, Leonardo A ^a  

^a UNIVERSITY OF UDINE   (Italy)

Author keywords

Carotid arteries; Fibrin D dimer; Fibrinogen; Intima media thickness

Indexed keywords

C REACTIVE PROTEIN; D DIMER; FIBRIN; FIBRINOGEN; HOMOCYSTEINE; LIPOPROTEIN; PROTHROMBIN;

ADULT; ARTERIAL WALL THICKNESS; ARTERY INJURY; ARTICLE; ATHEROSCLEROTIC PLAQUE; B SCAN; BLOOD VESSEL INJURY; BODY MASS; CAROTID ARTERY; CIGARETTE SMOKING; CLINICAL ASSESSMENT; CONTROLLED STUDY; CREATININE CLEARANCE; DISEASE DURATION; FEMALE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PROTEIN BLOOD LEVEL; PROTHROMBOTIC STATE; PULSE PRESSURE; REGRESSION ANALYSIS; THROMBOSIS; WAIST CIRCUMFERENCE;

EID: 84861584680     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.10819     Document Type: Article

References (36)

1. Simon A, Megnien JL, Levenson J: Coronary risk estimation and treatment of hypercolesterolemia. Circulation, 1997; 96: 2449-2452
2. Aminbakhsh A, Mancini GB: Carotid intima-media thickness measurement: what defines an abnormality? A systematic review. Clin Invest Med, 1999; 22: 149-157
3. Irie Y, Sakamoto K, Kubo F, Okusu T, Katura T, Yamamoto Y, Umayahara Y, Katakami N, Kaneto H, Kashiyama T, Ueda Y, Kosugi K: Association of coronary artery stenosis with carotid atherosclerosis in asymptomatic type 2 diabetic patients. J Atheroscler Thromb, 2011; 18(4): 337-344
4. Ohnishi H, Sawayama Y, Furusyo N, Maeda S, Tokunaga S, Hayashi J: Risk factors for and the prevalence of peripheral arterial disease and its relatiomship to carotid atherosclerosis: the Kyushu and Okinawa population Study (KOPS). J Atheroscler Thromb, 2010; 17: 751-758
5. Kablak-Ziembicka A, Przewlocki T, Sokolowski A, Tracz W, Podolec P: Carotid intima-media thickness, hs-CRP and TNF-α are independently associated with cardiovascular event risk in patients with atherosclerotic occlusive disease. Atherosclerosis, 2011; 214: 185-190
6. The task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC): 2007 Guidelines for the management of arterial hypertension. J Hypertens, 2007; 25: 1105-1187
7. Simon A, Gariepy J, Chironi G, Megnien JL, Levenson J: Intima-media thickness: a new tool for diagnosis and treatment of cardiovascular risk. J Hypertens, 2002; 20: 159-169
8. Catena C, Novello M, Lapenna R, Baroselli S, Colussi GL, Nadalini E, Favret G, Cavarape A, Soardo G, Sechi LA: New risk factors for atherosclerosis in hypertension: focus on the prothrombotic state and lipoprotein(a). J Hypertens, 2005; 23: 1617-1631
9. Folsom AR: Hemostatic risk factors for atherosclerotic disease: an epidemiologic view. Thromb Haemost, 2001; 86: 366-373
10. Koenig W: Fibrinogen in cardiovascular disease: an update. Thromb Haemost, 2003; 89: 601-609
11. Ridker PM, Hennekens CH, Cerskus A, Stampfer MJ: Plasma concentrations of cross-linked fibrin degradation product (D-dimer) and the risk of future myocardial infarction among apparently healthy men. Circulation, 1994; 90: 2236-2240
12. Cushman M, Lemaitre RN, Kuller LH, Psaty BM, Macy EM, Sharrett AR, Tracy RP: Fibrinolytic activation markers predict myocardial infarction in the elderly. The Cardiovascular Health Study. Arterioscler Thromb Vasc Biol, 1999; 19: 493-498
13. Sechi LA, Zingaro L, Catena C, Casaccio D, De Marchi S: Relationship of fibrinogen levels and hemostatic abnormalities with organ damage in hypertension. Hypertension, 2000; 36: 978-985
14. Pàramo JA, Orbe J, Beloqui O, Benito A, Colina I, Martinez-Vila E, Diez J: Prothrombin fragment 1+2 is associated with carotid intima-media thickness in subjects free of clinical cardiovascular disease. Stroke, 2004; 35: 1085-1089
15. Sechi LA, Kronenberg F, De Carli S, Falleti E, Zingaro L, Catena C, Utermann G, Bartoli E: Association of serum lipoprotein(a) and size apolipoprotein(a) polimorphism with target-organ damage in arterial hypertension. JAMA, 1997; 277: 1689-1695
16. Stein JH, Korcarz CE, Todd Hurst R, Lonn E, Kendall CB, Mohler ER, Najjar SS, Rembold CM, Post WS: Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a Consensus Statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. J Am Soc Echocardiogr, 2008; 21: 93-111
17. Friedewald WT, Levi RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative centrifuge. Clin Chem, 1972; 18: 499-502
18. Rossi E, Mondonico P, Lombardi A, Preda L: Method for determination of functional (clottable) fibrinogen by the new family of ACL coagulometers. Thromb Res, 1988; 52: 453-468
19. Pelzer H, Schwarz A, Stuber W: Determination of human prothrombin activation fragment 1+2 in plasma with an antibody against a synthetic peptide. Thromb Haemost, 1991; 65: 153-159
20. Rylatt DB, Blake AS, Cottis LE, Massingham DA, Fletcher WA, Masci PP, Whitaker AN, Elms M, Bunce I, Webber AJ: An immunoassay for human D-dimer using monoclonal antibodies. Thromb Res, 1983; 31: 767-778
21. Sechi LA, Catena C, Zingaro L, Melis A, De Marchi S: Abnormalities of glucose metabolism in patients with early renal failure. Diabetes, 2002; 51: 1226-1232
22. Salomaa V, Stinson JD, Kark JD, Folsom AR, Davis CE, Wu KK: Association of fibrinolytic parameters with early atherosclerosis. The ARIC study. Circulation, 1995; 91: 284-290
23. De Maat MDM, Bladbjerg EM, Drivsholm T, Borch-Johnsen K, Moller L, Jespersen J: Inflammation, thrombosis and atherosclerosis: results of the Glostrup study. J Thromb Haemost, 2003; 1: 950-957
24. Lee AJ, Mowbray PI, Lowe GDO, Rumley A, Fowkes GR, Allan PL: Blood viscosity and elevated carotid intima- media thickness in men and women. The Edinburgh Artery Study. Circulation, 1998; 97: 1467-1473
25. Grebe MT, Luu B, Sedding D, Heidt MC, Kemkes-Matthes B, Schaefer CA, Tllmans HH, Gunduz D: Fibrinogen promotes early atherosclerotic changes of the carotid artery in young, healthy adults. J Atheroscler Thromb, 2010; 17: 1003-1008
26. Corrado E, Rizzo M, Muratori I, Coppola G, Novo S: Association of elevated fibrinogen C-reactive protein levels with carotid lesions in patients with newly diagnosed hypertension or type II diabetes. Arch Med Res, 2006; 37: 1004-1009
27. Brzosko S, Hryszko T, Lebkowska U, Malyszko JS, Mysliwiec M: Plasma tissue-type plasminogen activator, fibrinogen, and time on dialysis prior to transplantation are related to carotid intima-media thickness in renal transplant recipients. Transplant Proc, 2003; 35: 2931-2934
28. Faintuch J, Marques PC, Bortolotto LA, Faintuch JJ, Cecconello I: Systemic inflammation and cardiovascular risk factors: are morbidly obese subjects different? Obes Surg, 2008; 18: 854-862
29. Haiashy S: Significance of plasma D-dimer in relation to the severity of atherosclerosis among patients evaluated by non-invasive indices of cardio-ankle vascular index and carotid intima-media thickness. Int J Hematol, 2010; 92: 76-82
30. Meade TW, Mellows S, Brozovic M: Haemostatic function and ischemic heart disease: principal results of the Northwick Park Heart Study. Lancet, 1986; II: 533-537
31. Wilhelmsen L, Svardsudd K, Koran-Bengtsen K, Larsson B, Weilin L, Tibblin G: Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med, 1984; 11: 501-505
32. Fowkes FGR, Housley E, Cawood EHH, Macintyre CCA, Ruckley CV, Prescott RJ: Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int Epidemiol, 1991; 20: 384-392
33. Koenig W, Ernst E: Fibrinogen and atherothrombogenesis. Curr Opin Lipidol, 1993; 4: 471-476
34. Graeff H, Hafter R: Detection and relevance of cross linked fibrin derivates in blood. Semin Thromb Haemost, 1982; 8: 57-68
35. Smith FB, Lee AJ, Fowkes FG, Price JF, Rumley A, Lowe GD: Hemostatic factors as predictors of ischemic heart disease and stroke in the Edinburgh Artery Study. Arterioscler Thromb Vasc Biol, 1997; 17: 3321-3325
36. Fowkes SG, Lowe GD, Housley E, Rattray A, Elton RA: Cross-linked fibrin degradation products, progression of peripheral arterial disease, and risk of coronary heart disease. Lancet, 1993; 342: 84-86